These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 6814335)

  • 1. [Development of a splenic infection in mice of 4 strains, inoculated by the venous route, with 3 doses of Brucella abortus].
    Plommet M; Plommet AM
    Ann Rech Vet; 1982; 12(4):345-51. PubMed ID: 6814335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of Brucella abortus, Brucella melitensis and Brucella and Brucella suis infection infection in mice to a chronic stage and cure].
    Bosseray N; Plommet M; De Rycke J
    Ann Rech Vet; 1982; 13(2):153-61. PubMed ID: 7168538
    [No Abstract]   [Full Text] [Related]  

  • 3. [Influence of the mouse genotype on the sensitivity to Brucella abortus 544].
    Le Garrec Y; Garrido-Calderon N; Pilet C
    Dev Biol Stand; 1976; 31():287-92. PubMed ID: 816685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Course of chronic brucellosis in mice is not improved by administration of a vaccinal antigen].
    Plommet M; Plommet AM; Bosseray N
    Ann Rech Vet; 1982; 13(2):127-32. PubMed ID: 6820248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance of Brucella abortus infected mice to intravenous or intraperitoneal Brucella reinfection.
    Pardon P; Marly J
    Ann Immunol (Paris); 1976; 127(1):57-70. PubMed ID: 821385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Killed vaccine in adjuvant and protection of mice against an intraperitoneal challenge of Brucella: kinetic studies.
    Pardon P; Marly J
    Ann Rech Vet; 1976; 7(4):297-305. PubMed ID: 829301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunologic, histopathologic, and bacteriologic responses of five strains of mice to Brucella abortus strain 2308.
    Pugh GW; Zehr ES; Meador VP; Phillips M; McDonald TJ; Deyoe BL
    Am J Vet Res; 1989 Mar; 50(3):323-8. PubMed ID: 2494913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Brucella cell-mediated immunity in mice vaccinated with a cell-wall fraction.
    Plommet M; Plommet AM
    Ann Rech Vet; 1987; 18(4):429-37. PubMed ID: 3451687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of placental colonization of mice inoculated intravenously with Brucella abortus at day 15 of pregnancy.
    Bosseray N
    Br J Exp Pathol; 1983 Dec; 64(6):612-6. PubMed ID: 6419765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome and immune responses after Brucella abortus infection in young adult and aged mice.
    High KP; Prasad R; Marion CR; Schurig GG; Boyle SM; Sriranganathan N
    Biogerontology; 2007 Oct; 8(5):583-93. PubMed ID: 17653832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virulence of Brucella: bacterial growth and decline in mice.
    Plommet M; Plommet AM
    Ann Rech Vet; 1988; 19(1):65-7. PubMed ID: 3135775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A bile salt hydrolase of Brucella abortus contributes to the establishment of a successful infection through the oral route in mice.
    Delpino MV; Marchesini MI; Estein SM; Comerci DJ; Cassataro J; Fossati CA; Baldi PC
    Infect Immun; 2007 Jan; 75(1):299-305. PubMed ID: 17088355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increases of efficacy as vaccine against Brucella abortus infection in mice by simultaneous inoculation with avirulent smooth bvrS/bvrR and rough wbkA mutants.
    Grilló MJ; Manterola L; de Miguel MJ; Muñoz PM; Blasco JM; Moriyón I; López-Goñi I
    Vaccine; 2006 Apr; 24(15):2910-6. PubMed ID: 16439039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mother to young transmission of Brucella abortus infection in mouse model.
    Bosseray N
    Ann Rech Vet; 1982; 13(4):341-9. PubMed ID: 6821020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brucella abortus cyclic beta-1,2-glucan mutants have reduced virulence in mice and are defective in intracellular replication in HeLa cells.
    Briones G; Iñón de Iannino N; Roset M; Vigliocco A; Paulo PS; Ugalde RA
    Infect Immun; 2001 Jul; 69(7):4528-35. PubMed ID: 11401996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of Brucella abortus on growth of ovarian granulosa cell carcinoma].
    Litvinkova NP; Trubcheninova LP; Baryshnikov AIu
    Biull Eksp Biol Med; 1980 Nov; 90(11):600-2. PubMed ID: 6778536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An aerosolized Brucella spp. challenge model for laboratory animals.
    Olsen SC; Waters WR; Stoffregen WS
    Zoonoses Public Health; 2007; 54(8):281-5. PubMed ID: 17894637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced efficacy of recombinant Brucella abortus RB51 vaccines against B. melitensis infection in mice.
    Vemulapalli R; Contreras A; Sanakkayala N; Sriranganathan N; Boyle SM; Schurig GG
    Vet Microbiol; 2004 Sep; 102(3-4):237-45. PubMed ID: 15327798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental Brucella abortus infection in the horse: observations during the three months following inoculation.
    MacMillan AP; Baskerville A; Hambleton P; Corbel MJ
    Res Vet Sci; 1982 Nov; 33(3):351-9. PubMed ID: 6818648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody-mediated protection against Brucella abortus in BALB/c mice at successive periods after infection: variation between virulent strain 2308 and attenuated vaccine strain 19.
    Elzer PH; Jacobson RH; Jones SM; Nielsen KH; Douglas JT; Winter AJ
    Immunology; 1994 Aug; 82(4):651-8. PubMed ID: 7835931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.